Coronavirus Disease 2019 (COVID-19) in a Renal Transplant Patient

Coronavirus disease 2019 (COVID-19) has resulted in significant morbidity and mortality worldwide. Transplant patients are particularly at a higher risk of contracting COVID-19 because of their immunosuppressed state, and they have the propensity to develop opportunistic infections. The pre-immunosu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chenna, Avantika, Konala, Venu Madhav, Gayam, Vijay, Naramala, Srikanth, Adapa, Sreedhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282362/
https://www.ncbi.nlm.nih.gov/pubmed/32528774
http://dx.doi.org/10.7759/cureus.8038
Descripción
Sumario:Coronavirus disease 2019 (COVID-19) has resulted in significant morbidity and mortality worldwide. Transplant patients are particularly at a higher risk of contracting COVID-19 because of their immunosuppressed state, and they have the propensity to develop opportunistic infections. The pre-immunosuppressed state, along with other existing comorbidities, can influence the outcomes of COVID-19 in transplant patients. We describe a case of a renal transplant patient who developed COVID-19. Real-time nucleic acid testing (NAT) should be done in deceased and living donors. The most common management strategy is the modification of immunosuppression along with current experimental strategies for COVID-19.

Ejemplares similares